Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Preferential Issue

 The Board of Directors have at their meeting held today, 04-July-2024 have approved the proposal to raising of funds by issue and allotment of 9,00,000 warrants each convertible into 1 (one) equity share of Rs.10/- each to the promoters of the Company on a preferential basis, subject to regulatory, statutory and members'' approval. The Board will be seeking shareholders'' approval in an Extraordinary General Meeting of which Notice will issued separately.
04-07-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Board Meeting Intimation For Raising Of Fund Through Preferential Issue

 Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2024 ,inter alia, to consider and approve To consider proposal for raising of funds by way of issue of one or more of instruments comprising of equity shares, convertible securities of any other description or warrants or debt securities, through Private Placement / Preferential Issue / Qualified Institutions Placement or such other methods or combinations thereof and to approve ancillary actions for the above mentioned fund raising, subject to such statutory / regulatory approvals as may be necessary.
01-07-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Announcement Under Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Declaration of successfully completion of first milestone in Development (R&D) & Manufacturing Sample of Vitamin B1 (Thiamine Hydrochloride) finish API.
22-06-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Financial Results for the half year and financial year ended 31-March-2024
29-05-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management

 APPOINTMENT OF MR NILESH THAKKAR , DR VISHVAS JOSHI, DR TAPAS KUMAR NANDI AND MR NIRAV SHAH AT THE BOARD MEETING HELD ON 27.05.2024
27-05-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - FINANCIAL RESULT FOR THE HALF YEAR AND FINANCIAL YEAR ENDED MARCH 31, 2024

 FINANCIAL RESULT FOR THE HALF YEAR AND FINANCIAL YEAR ENDED MARCH 31, 2024
27-05-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On May 27, 2024.

 Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Board Meeting to be scheduled on 27th May 2024 to discuss and consider the agendas as per the attachment annexed.
20-05-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Sudarshan Pharma Industries Ltd 2 CIN NO. U51496MH2008PLC184997 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 0 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)0 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Designation :- Name of the Chief Financial Officer :- Designation : - Date: 30/04/2024
30-04-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Certificate Pursuant To Reg. 40(9) & 40(10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015.

 Sudarshan Pharma Industries Limited intimates the Exchange regarding the Certificate pursuant to Reg 40(9) & 40(10) of SEBI (Listing Obligation & Disclosure Requirements) Regulations,2015.
25-04-2024
Bigul

Sudarshan Pharma Industries Ltd - 543828 - Compliances-Compliance Certificate For The Period Ended March, 2024.

 Compliance Certificate pursuant to Regulation 7(3) of SEBI (LODR) Regulations 2015.
20-04-2024
Next Page
Close

Let's Open Free Demat Account